These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2578244)

  • 1. Polymorphic ventricular tachycardia and ventricular fibrillation due to N-acetyl procainamide.
    Herre JM; Thompson JA
    Am J Cardiol; 1985 Jan; 55(1):227-8. PubMed ID: 2578244
    [No Abstract]   [Full Text] [Related]  

  • 2. N-acetyl procainamide causing torsades de pointes.
    Olshansky B; Martins J; Hunt S
    Am J Cardiol; 1982 Dec; 50(6):1439-41. PubMed ID: 6183970
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of torsade de pointes induced by N-acetyl procainamide].
    Fujii T; Ohe T; Deguchi F; Shimomura K; Ito K
    Kokyu To Junkan; 1987 Feb; 35(2):197-201. PubMed ID: 2437626
    [No Abstract]   [Full Text] [Related]  

  • 4. Torsade de pointes associated with elevated N-acetylprocainamide levels.
    Stratmann HG; Walter KE; Kennedy HL
    Am Heart J; 1985 Feb; 109(2):375-7. PubMed ID: 2578241
    [No Abstract]   [Full Text] [Related]  

  • 5. Torsade de pointes induced by N-acetylprocainamide.
    Chow MJ; Piergies AA; Bowsher DJ; Murphy JJ; Kushner W; Ruo TI; Asada A; Talano JV; Atkinson AJ
    J Am Coll Cardiol; 1984 Sep; 4(3):621-4. PubMed ID: 6206104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.
    Roden DM; Reele SB; Higgins SB; Wilkinson GR; Smith RF; Oates JA; Woosley RL
    Am J Cardiol; 1980 Sep; 46(3):463-8. PubMed ID: 6158263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal accumulation of procainamide metabolite in severe renal insufficiency.
    Vlasses PH; Ferguson RK; Rocci ML; Raja RM; Porter RS; Greenspan AM
    Am J Nephrol; 1986; 6(2):112-6. PubMed ID: 2422935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias.
    Harron DW; Brogden RN
    Drugs; 1990 May; 39(5):720-40. PubMed ID: 1693889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylprocainamide and ischemia-induced ventricular fibrillation in the dog.
    Reynolds RD; Kamath BL
    Eur J Pharmacol; 1979 Oct; 59(1-2):115-9. PubMed ID: 92414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
    Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
    Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procainamide-induced polymorphous ventricular tachycardia.
    Strasberg B; Sclarovsky S; Erdberg A; Duffy CE; Lam W; Swiryn S; Agmon J; Rosen KM
    Am J Cardiol; 1981 Jun; 47(6):1309-14. PubMed ID: 7234705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: successful treatment of ventricular tachycardia associated with thioridazine (Mellaril).
    Tranum BL; Murphy ML
    South Med J; 1969 Mar; 62(3):357-8. PubMed ID: 5765133
    [No Abstract]   [Full Text] [Related]  

  • 14. N-acetylprocainamide's antiarrhythmic action in patients with ventricular tachycardia.
    Somberg J; Wynn J; Miura D; Torres V; Williams S; Keefe D
    Angiology; 1986 Dec; 37(12 Pt 2):972-81. PubMed ID: 2433972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylprocainamide, torsades de pointes, and hemodialysis.
    Nguyen KP; Thomsen G; Liem B; Swerdlow CD; Franz MR
    Ann Intern Med; 1986 Feb; 104(2):283-4. PubMed ID: 2418719
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of N-acetylprocainamide in long-term treatment of ventricular arrhythmias.
    Atkinson AJ; Lertora JJ; Kushner W; Chao GC; Nevin MJ
    Clin Pharmacol Ther; 1983 May; 33(5):565-76. PubMed ID: 6188570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term antiarrhythmic therapy with acetylprocainamide.
    Kluger J; Leech S; Reidenberg MM; Lloyd V; Drayer DE
    Am J Cardiol; 1981 Dec; 48(6):1124-32. PubMed ID: 6171156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of procainamide on fibrillation threshold of normal and ischemic ventricles.
    Yoon MS; Han J; Goel BG; Creamer P
    Am J Cardiol; 1974 Feb; 33(2):238-42. PubMed ID: 4810021
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670
    [No Abstract]   [Full Text] [Related]  

  • 20. Acecainide for ventricular arrhythmias.
    Vyden JK
    JAMA; 1982 Feb; 247(5):581. PubMed ID: 6172606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.